Scientist behind Vertex CF drugs launches new startup with Atlas Venture

Jonathan Moore, one of the first employees of Vertex Pharmaceuticals Inc. and a key scientist behind the company's renowned cystic fibrosis drugs, has a new venture. Rectify Pharmaceuticals has ambitious plans to target proteins that affect multiple organ systems including the lungs, liver, gastrointestinal tract, eye and central nervous system. The focus of the new startup are something called ATP-binding cassette (ABC) transporters, which are membrane proteins that are crucial to moving substrates…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news